Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.

Martin, NK; Vickerman, P; Foster, GR; Hutchinson, SJ; Goldberg, DJ; Hickman, M; (2011) Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. Journal of hepatology, 54 (6). pp. 1137-44. ISSN 0168-8278 DOI: https://doi.org/10.1016/j.jhep.2010.08.029

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jhep.2010.08.029

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar